• 1
    Irving GA. Perioperative blood and blood component therapy. Canadian Journal of Anaesthesiology 1992; 39: 110515.
  • 2
    Chernow B. Blood conservation in critical care — The evidence accumulates. Critical Care Medicine 1993; 21: 4812.
  • 3
    McClelland DB. ABC of tranfusion. Human albumin solutions. British Medical Journal 1990; 300: 357.
  • 4
    Strauss RG, Stansfield C, Henriksen RA, Villhauer PJ. Pentastarch may cause fewer effects on coagulation than hetastarch. Transfusion 1988; 28: 25760.
  • 5
    Vogt NH, Bothner U, Lerch G, Lindner KH, Georgieff M. Large-dose administration of 6% hydroxyethyl starch 200/0.5 for total hip arthroplasty: plasma homeostasis, haemostasis, and renal function compared to use of 5% human albumin. Anesthesia and Analgesia 1996; 83: 2628.
  • 6
    Laxenaire MC, Charpentier C, Feldman L. Anaphylactoid reactions to colloid plasma substitutes: incidence, risk factors, mechanisms. A French multicenter prospective study. Annales Francaises d'Anesthesie et de Reanimation 1994; 13: 30110.
  • 7
    Lundsgaard-Hansen P & Pappova E. Component cell therapy of surgical haemorrhage: red cells, plasma substitutes and albumin. Annals of Clinical Research 1981; 13 2: 2638.
  • 8
    Durand Zaleski I, Bonnet F, Rochant H, Bierling P, Lemaire F. Usefulness of consensus conferences: the case of albumin. Lancet 1992; 340: 138890.
  • 9
    Moss GS, Lowe RJ, Jilek J, Levine HD. Colloid or crystalloid in the resuscitation of haemorrhagic shock: a controlled clinical trial. Surgery 1981; 89: 4348.
  • 10
    Sun X, Iles M, Weissman C. Physiologic variables and fluid resuscitation in the postoperative intensive care unit patient. Critical Care Medicine 1993; 21: 55561.
  • 11
    Kaminski M & Williams S. Review of the rapid normalization of serum albumin with modified tatal parenteral nutrition solutions. Critical Care Medicine 1990; 18: 327.
  • 12
    Lundsgaard-Hansen P. Physiology and pathophysiology of colloid osmotic pressure and albumin metabolism. Current Studies of Hematology and Blood Transfusion 1986; 117.
  • 13
    Nearman HS & Herman ML. Toxic effects of colloids in the intensive care unit. Critical Care Clinics 1991; 7: 71323.
  • 14
    Bergqvist D. Dextran and haemostasis. A review. Acta Chirurgica Scandinavica 1982; 148: 63340.
  • 15
    London MJ, Franks M, Verrier ED, Merrick SH, Levin J, Mangano DT. The safety and efficacy of ten percent pentastarch as a cardiopulmonary bypass priming solution. A randomized clinical trial. Journal of Thoracic and Cardiovascular Surgery 1992; 104: 28496.
  • 16
    Shatney CH, Deepika K, Militello PR, Majerus TC, Dawson RB. Efficacy of hetastarch in the resuscitation of patients with multisystem trauma and shock. Archives of Surgery 1983; 118: 8049.
  • 17
    Villarino ME, Gordon SM, Valdon C, et al A cluster of severe postoperative bleeding following open heart surgery. Infection Control and Hospital Epidemiology 1992; 13: 2827.
  • 18
    Dalrymple-Hay M, Aitchison R, Collins P, Sekhar M, Colvin B. Hydroxyethyl starch induced acquired von Willdebrand's disease. Clinical and Laboratory Haematology 1992; 14: 20911.
  • 19
    London MJ, Ho JS, Triedman JK, et al A randomized clinical trial of 10% pentastarch (low molecular weight hydroxyethyl starch) versus 5% albumin for plasma volume expansion after cardiac operations. Journal of Thoracic and Cardiovascular Surgery 1989; 97: 78597.
  • 20
    Kapiotis S, Quehenberger P, Eichler H-H, et al Effect of hydroxyethyl starch on the activity of blood coagulation and fibrinolysis in healthy volunteers: comparison with albumin. Critical Care Medicine 1994; 22: 60612.
  • 21
    Legendre C, Thervet E, Page B, Percheron A, Noël LH, Kreis H. Hydroxyethylstarch and osmotic-nephrosis-like lesions in kidney transplantation. Lancet 1993; 342: 2489.
  • 22
    Schlumpf R, Morel P, Loveras JJ, et al Examination of the role of the colloids hydroxyethylstarch, dextran, human albumin, and plasma proteins in a modified UW solution. Transplantation Proceedings 1991; 23: 23625.
  • 23
    Waldhausen P, Kiesewetter H, Leipnitz G, et al Hydroxyethyl starch-induced transient renal failure in preexisting glomerular damage. Acta Medica Austriaca 1991; 18 2: 525.
  • 24
    Biguzas M, Jablonski P, Thomas AC, et al Evaluation of UW solution in a rat kidney preservation model. I. Effect of hydroxyethyl start and electrolyte composition. Transplantation 1990; 49: 8725.